Specifically, GGCT has been confirmed to activate the PI3K/AKT/mTOR signaling, thereby driving the malignant progression of ovarian cancer, hepatocellular carcinoma, and breast cancer [11,12,13]
Areas of interest include, but are not limited to: Classic antidiabetic, anti-obesity and cardioprotective effects Cardiovascular outcomes and mechanistic correlates Endothelial and vascular biology Myocardial metabolism and heart failure subtypes Novel renal and hepatoprotective actions Optimization and individualized use of existing GLP-1 receptor agonists Development of novel GLP-1 receptor agonists and multi-agonist (dual and triple) strategies Emerging extra-metabolic actions, including anti-inflammatory and neuroprotective effects Combination therapies, including co-formulations with insulin or SGLT2 inhibitors Innovative delivery systems, including non-injectable and implantable approaches Real-world comparative effectiveness, long-term safety, adherence and treatment durability This Collection welcomes original research, translational studies, and comprehensive reviews and meta-analyses that provide novel mechanistic insight or clinically relevant evidence to advance understanding of the expanding role of incretin-based therapies in cardiometabolic medicine
Bone Mineral Density Response to Caloric RestrictionInduced Weight Loss
And the manufacturer, Novo Nordisk, even says as much in the packaging insert, recommending that the weight-loss drug be stored between 36F and 46F
Moreover, oxidative stress in the kidneys can impair their ability to regulate sodium excretion and blood volume
[DOI] [PubMed] [Google Scholar] Kelley D.E., Goodpaster B., Wing R.R., Simoneau J.A
